| 标题 |
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Kidney international 作者:Barratt J; Lafayette R; Kristensen J; Stone A; Cattran D; et al 出版日期:2023/02/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)